Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +94.3% | +83.5% | 3 / 3 | +33.0% | +4.88 pp | +4.74 pp | +8.9% | 0.11 | 6.83 | 47,6 | +33,0% | 7,2 | +94,3% | 6.83 | 13.44 | −49,2% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.900 (close price on 2026-10-19)EPS (TTM): 1.010
Financial charts
1.Revenue & growth
VND bn47,6Q2/26
1.Revenue & growth
VND bn47,6Q2/26
2.Profit & growth
VND bn6,91Q2/26
3.Profit mix (Penman)
VND bn21,5Q2/26
4.Margins & cost structure
%21.8%Q2/26
5.Returns & cash cycle
% · days9.2%Q2/26
6.Earnings quality & cash
VND bn46,4Q2/26
7.Asset structure
VND bn256Q2/26
8.Funding & debt health
VND bn · times256Q2/26
9.Revenue backlog
VND bn0,27Q2/26
10.Valuation
times · %6,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %401Q2/26
Adjusted EPS growth, latest quarter
87.7%
Average adjusted EPS growth, 3 quarters
81.3%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26